Literature DB >> 23102787

Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side?

Michel R Langlois, Joris R Delanghe, Marc De Buyzere, Ernst Rietzschel, Dirk De Bacquer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23102787     DOI： 10.1016/j.atherosclerosis.2012.10.036

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  4 in total

1.  The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.

Authors:  Martin B Mortensen; Shoaib Afzal; Børge G Nordestgaard; Erling Falk
Journal:  Eur Heart J       Date:  2015-06-16       Impact factor: 29.983

2.  Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.

Authors:  Julian P Halcox; José R Banegas; Carine Roy; Jean Dallongeville; Guy De Backer; Eliseo Guallar; Joep Perk; David Hajage; Karin M Henriksson; Claudio Borghi
Journal:  BMC Cardiovasc Disord       Date:  2017-06-17       Impact factor: 2.298

3.  Estimation of cardiovascular risk based on total cholesterol versus total cholesterol/high-density lipoprotein within different ethnic groups: The HELIUS study.

Authors:  Wilco Perini; Marieke B Snijder; Ron J Peters; Anton E Kunst; Irene G van Valkengoed
Journal:  Eur J Prev Cardiol       Date:  2019-06-01       Impact factor: 7.804

Review 4.  High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  BBA Clin       Date:  2015-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.